1313237-12-5

Upstream product

• 5159-41-1 2-iodobenzyl alcohol 
• 1313236-57-5 1-tert-butyl 4-ethyl 4-(2-cyanoethyl)piperidine-1,4-dicarboxylate 
• 1313237-25-0 2-(2-(bromomethyl)phenyl)-2H-1,2,3-triazole 
• 1198284-94-4 tert-butyl 1-oxo-2,9-diazaspiro[5.5]undecane-9-carboxylate 
• 1313237-23-8 (2-(2H-1,2,3-triazol-2-yl)phenyl)methanol 
• 142851-03-4 1-tert-butyl 4-ethyl piperidine-1,4-dicarboxylate 

Downstream Products

• 1313234-50-2 2-(2-(2H-1,2,3-triazol-2-yl)benzyl)-9-(quinoxalin-2-yl)-2,9-diazaspiro[5.5]undecan-1-one 
• 1373765-08-2 2-(2-(2H-1,2,3-triazol-2-yl)benzyl)-9-(4,6-dimethylpyrimidin-2-yl)-2,9-diazaspiro[5.5]undecan-1-one 

Relevant academic research and scientific papers

Diaza-spiro[5.5]undecanes

The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.

DIAZA-SPIRO[5.5]UNDECANES AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.